P1086 Re-administration of infliximab in patients with extremely refractory perianal Crohn’s disease von Mousourakis, K, Veretanos, C, Arvanitis, K, Georgiadi, T, Nousias, G, Kozompoli, D, Mylonas, I, Paparizou, A, Karaouzas, L, Kalogiros, G, Patsi, M, Provi, D, Christidou, A, Mela, M, Archavlis, E, Papastergiou, V, Varytimiadis, K, Katopodi, K, Chatzievangelinou, C, Viazis, N

Volltext

Scale up of hepatitis C virus treatment in the era of all-oral direct-acting antivirals: a 9-year Greek cohort study von Papastergiou, V., Deutsch, M., Mela, M., Triantos, C., Kranidioti, H., Chatzievangelinou, C., Zisimopoulos, K., Anagnostou, O., Papatheodoridis, G., Manolakopoulos, S.

Volltext

THU-086 - Scale up of hepatitis C virus treatment in the era of all-oral direct-acting antivirals: a 9-year Greek cohort study von Papastergiou, V., Deutsch, M., Mela, M., Triantos, C., Kranidioti, H., Chatzievangelinou, C., Zisimopoulos, K., Anagnostou, O., Papatheodoridis, G., Manolakopoulos, S.

Volltext

P659 Efficacy of switching from infliximab to golimumab in ulcerative colitis patients on deep remission von Viazis, N, Pontas, C, Gazouli, M, Tsigaridas, T, Tziortziotis, I, Chatzievangelinou, C, Gkeros, F, Vraka, M, Tsatsa, A, Tsoukali, E, Galanopoulos, M, Mantzaris, G J

Volltext